An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP.
- DOI
- 10.1093/rheumatology/keaf291
- Published
- 2025 Oct 1
- Container
- Rheumatology (Oxford, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/rheumatology/keaf291,
title = {An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP.},
author = {Herrick AL and Murray A and Dinsdale G and Manning J and Chukwu C and Alvarez Fernandez M and Axling U and Seibold JR and Tiberg F},
year = {2025},
journal = {Rheumatology (Oxford, England)},
doi = {10.1093/rheumatology/keaf291},
url = {https://doi.org/10.1093/rheumatology/keaf291}
}RIS
TY - JOUR TI - An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP. AU - Herrick AL AU - Murray A AU - Dinsdale G AU - Manning J AU - Chukwu C AU - Alvarez Fernandez M AU - Axling U AU - Seibold JR AU - Tiberg F PY - 2025 JO - Rheumatology (Oxford, England) DO - 10.1093/rheumatology/keaf291 UR - https://doi.org/10.1093/rheumatology/keaf291 ER -
APA
AL, H., A, M., G, D., J, M., C, C., M, A. F., U, A., JR, S., & F, T. (2025). An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keaf291
Source records
- pubmed · retrieved 2026-09-26T02:14:12.177Z
- europe-pmc · retrieved 2026-09-26T02:14:12.189Z